Your right Muck, with all arql has accomplished this year and the stock mkt. at 4yr. high and ASCO around the corner, we are exactly where we were this time last yr. Stock lost all it's momentum with dilution.Sucks big time.
yikes...unfortunately, we're all familiar with this script. It's going to be a long summer I'm guessing. I do know if I sell the next morning Astellas (OSIP/Tarceva) and DS will get into a bidding war for ARQL!
Biotech can be pretty frustrating but of course bottom line, we need sigificant ph 3 results.